TPP Healthcare announced a successful partnering event with Wilson Sonsini Goodrich & Rosati (WSGR) at the inaugural TPP MedTech China Forum, which took place on Thursday, June 25, 2015 — adjoined to WSGR’s 23rd Annual Medical Device Conference the following day.
The event composed of 50 US healthcare and life sciences companies in a diversity of areas within medical technology as well as a range of Chinese investment groups looking for products and technologies appropriate for China’s market. With over 150 prearranged meetings that took place during the event, US companies met with Chinese groups looking to invest in, license, and distribute their products and technologies. The opportunity to collaborate at one of WSGR’s premier events allowed TPP a platform to reach a wide range of companies in a variety of spaces, all with interest in reaching the Chinese market. Meetings encouraged participants to engage in conversations regarding the most relevant paths for market entrance according to their specific products and technologies as well as appropriate deal terms and execution plans.
The collaboration continued as TPP Founding Partner Asa Cox was featured along with several expert advisors and investors on the International Funding Strategies in China panel at WSGR’s Medical Device Conference on the 26th.